큐리옥스바이오시스템즈
445680KOSDAQ의료용 기기 제조업43.8 / 100
Reference Date: 2026-07-24
Company InformationBased on 2025 Annual Report
Business Overview
Curiox Biosystems sells automated equipment and consumables for cell analysis processes, leveraging its decade-long developed Curiox C-FREE™ technology to automate preprocessing steps, significantly improving data accuracy and reproducibility. This technology, based on microfluidics and surface science, is used by pharmaceutical companies and research institutions in the US, Europe, and China. The company has subsidiaries in the US, China, and Singapore to expand its global market presence.
Number of Employees
22people
Average Salary
70.4M KRW
Score Calculation Basis
Detailed Financial Score
10.7x industry avg (risky)
Well below industry avg
Half of industry avg (excellent)
Avg ▼10.1% (2-year basis)
Avg ▼9.4% (2-year basis)
Avg ROE -30.1% (declining, 3yr)
Detailed News Sentiment
- Positive큐리옥스, '장비'서 '소프트웨어'로 사업 확대...빅파마 계약이 쏜 ...
큐리옥스바이오시스템즈는 소프트웨어 사업 확장을 통해 실적 개선과 성장 기회를 모색하고 있다.
Detailed Momentum
Near 52w low (2%, downtrend)
1m -18.74% (strong drop)
Volume decreasing
Detailed Disclosure
- Neutral전환사채(해외전환사채포함)발행후만기전사채취득 (제1회차)2026-06-29
